An experimental Alzheimer’s drug outperforms one just approved by the FDA

Patients in the early stages of Alzheimer’s may soon have a new option to stave off the loss of memory and thinking. In a study of more than 1,700 people, the experimental drug donanemab slowed the progression of Alzheimer’s by about 35%, scientists reported at the Alzheimer’s Association International Conference in Amsterdam. The result, published simultaneously in the journal JAMA, suggests…

Cameron releases public safety plan in bid to unseat Democratic Gov. Beshear

LOUISVILLE, Ky. — Republican gubernatorial nominee Daniel Cameron proposed awarding recruitment and retention bonuses to bolster police forces, part of a sweeping public safety plan unveiled Tuesday that calls for tougher penalties against drug traffickers found responsible for causing deaths in Kentucky. What You Need To Know Republican gubernatorial nominee Daniel Cameron unveiled his sweeping…